Sana Biotechnology, Inc.SANANASDAQ
Loading
Cash Generation ExpandingExpanding
Percentile Rank71
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Latest
$-144.77M
↑ 25% vs avg
Percentile
P71
Within normal range
Streak
3 yr
Consecutive growthExpanding
Average
$-194.29M
Historical baseline
PeriodValueYoY Change
TTM$-144.77M+43.6%
2024$-256.58M+6.2%
2023$-273.61M+12.0%
2022$-310.93M-10.7%
2021$-280.92M-73.6%
2020$-161.85M-44.9%
2019$-111.69M-700.3%
2018$-13.96M-